American College of Clinical Pharmacy

ACCP International Clinical Pharmacist Summer 2013ACCPInternational Clinical PharmacistEditor: Wafa Y. Dahdal, Pharm.D. • Winter 2018; Volume 7, Issue 4

The Board of Pharmacy Specialties (BPS) will offer the first cer-tification examinations for the cardiology pharmacy and infec-tious diseases pharmacy specialties in fall 2018. Pharmacists who meet the eligibility criteria and successfully pass the rel-evant examination will earn the credentials of Board Certified Cardiology Pharmacist (BCCP) or Board Certified Infectious Diseases Pharmacist (BCIDP). These two specialty certifica-tions were officially recognized as stand-alone specialties by BPS in February 2017.

As defined by the petitioning organizations, “Cardiology Pharmacy practice specializes in the delivery of direct patient care services by pharmacists as members of interprofes-sional healthcare teams, working to ensure the safe and effective use of medications in patients with cardiovascular disease. These specialists focus on disease prevention and treatment, including evidence-based medication use and related care that improve both short- and long-term out-comes for patients. Cardiology specialists practice across the spectrum of care, including ambulatory, acute and intensive care. Pharmacists in this practice review, analyze and monitor multifaceted clinical information to make reasoned decisions for patients with multiple comorbidities and highly complex mediation regimens.”

As defined by the petitioning organizations, “Infectious Diseases Pharmacy practice specializes in the use of microbi-ology and pharmacology to develop, implement, and monitor

drug regimens that incorporate the pharmacodynamics and pharmacokinetics of antimicrobials to optimize therapy for patients. The practice requires pharmacists to use clinical and evidence-driven knowledge to develop appropriate anti-microbial therapies to more rapidly resolve infections while decreasing adverse events, complications and resistance. The practice includes direct patient care provided through inter-professional health care teams, collaborative leadership of antimicrobial stewardship programs, education of health care providers, preventive services including immunizations, and advocacy for appropriate antimicrobial utilization. Specialty pharmacy practice in infectious diseases uniquely improves public health by optimizing antimicrobial potential in individ-ual patients and narrowing the resistance trends that occur in society by preventing progression of antimicrobial resistance and infectious diseases.”

The two new specialties, together with geriatric pharmacy, which also became part of BPS in 2017, bring the total num-ber of recognized pharmacy specialties to 11 (Figure).

Applications for both Cardiology Pharmacy and Infectious Diseases Pharmacy examinations will open May 7, 2018. More information on the two specialties is available at www.bpsweb.org/bps-specialties/cardiology-pharmacy and www.bpsweb.org/bps-specialties/infectious-diseases-pharmacy, respectively.

Cardiology and Infectious Diseases Pharmacy Specialty Certifications

Table of ContentsCardiology and Infectious Diseases Pharmacy Specialty Certifications ........................................................................................................... 1ACCP Launches a New Journal: JACCP ................................................................................................................................................................ 2Book Highlights ................................................................................................................................................................................................... 2Mark Your Calender ............................................................................................................................................................................................ 22018 Global Conference on Clinical Pharmacy to Be Held in Seattle ................................................................................................................ 3A Message from the Editor ................................................................................................................................................................................. 4

Cardiology and Infectious Diseases Pharmacy Specialty Certifications

The Board of Pharmacy Specialties (BPS) will offer the first certification examinations for the cardiology pharmacy and infectious diseases pharmacy specialties in fall 2018. Pharmacists who meet the eligibility criteria and successfully pass the relevant examination will earn the credentials of Board Certified Cardiology Pharmacist (BCCP) or Board Certified Infectious Diseases Pharmacist (BCIDP). These two specialty certifications were officially recognized as stand-alone specialties by BPS in February 2017.

As defined by the petitioning organizations, “Cardiology Pharmacy practice specializes in the delivery of direct patient care services by pharmacists as members of interprofessional healthcare teams, working to ensure the safe and effective use of medications in patients with cardiovascular disease. These specialists focus on disease prevention and treatment, including evidence-based medication use and related care that improve both short- and long-term outcomes for patients. Cardiology specialists practice across the spectrum of care, including ambulatory, acute and intensive care. Pharmacists in this practice review, analyze and monitor multifaceted clinical information to make reasoned decisions for patients with multiple comorbidities and highly complex mediation regimens.”

As defined by the petitioning organizations, “Infectious Diseases Pharmacy practice specializes in the use of microbiology and pharmacology to develop, implement, and monitor drug regimens that incorporate the pharmacodynamics and pharmacokinetics of antimicrobials to optimize therapy for patients. The practice requires pharmacists to use clinical and evidence-driven knowledge to develop appropriate antimicrobial therapies to more rapidly resolve infections while decreasing adverse events, complications and resistance. The practice includes direct patient care provided through interprofessional health care teams, collaborative leadership of antimicrobial stewardship programs, education of health care providers, preventive services including immunizations, and advocacy for appropriate antimicrobial utilization. Specialty pharmacy practice in infectious diseases uniquely improves public health by optimizing antimicrobial potential in individual patients and narrowing the resistance trends that occur in society by preventing progression of antimicrobial resistance and infectious diseases.”

The two new specialties, together with geriatric pharmacy, which also became part of BPS in 2017, bring the total number of recognized pharmacy specialties to 11 (Figure).

Figure. Timeline for BPS’s recognition of pharmacy specialties.

1978 Nuclear

Pharmacy

1988 Nutrition Support

Pharmacy; Pharmacotherapy

1992 Psychiatric Pharmacy

1996 Oncology Pharmacy

2009 Ambulatory

Care Pharmacy

2013 Critical Care Pharmacy; Pediatric

Pharmacy

2017Cardiology Pharmacy;

Infectious Diseases Pharmacy; Geriatric

Pharmacy

Figure. Timeline for BPS's recognition of pharmacy specialties.

American College of Clinical Pharmacy

ACCP International Clinical Pharmacist Winter 2018

2

. International clinical pharmacy practice . Medication optimization and patient outcomes . Practice-based implementation scienceJACCP will also publish ACCP official papers and board

certification modules. More information on JACCP is available at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2574-9870.

ACCP Launches a New Journal: JACCP

ACCP will launch a second journal, Journal of the American College of Clinical Pharmacy (JACCP). This peer-reviewed, online journal will focus on all aspects of clinical pharmacy practice. JACCP, with its new focus, will effectively comple-ment ACCP’s prominent journal Pharmacotherapy, which focuses on human pharmacology and pharmacotherapy.

JACCP is currently accepting submissions on the following topics: . Clinical pharmacy services delivery models . Clinical pharmacy education and training . Credentialing and privileging of clinical pharmacists . Economic outcomes of clinical pharmacy practice . Health care policy influencing clinical pharmacy . Innovations in clinical pharmacist practice

PHARMACOTHERAPY SELF-ASSESSMENT PROGRAM

Series EditorsJohn E. Murphy, Pharm,D., FCCP, FASHP and

Mary Wun-Len Lee, Pharm,D., FCCP, BCPS

2018 • BOOK 1

INFECTIOUS DISEASES

AMERICAN COLLEGE OF CLINICAL PHARMACY

Infectious Diseases

Released in January 2018, Infectious Diseases is the latest release in the Pharmacotherapy Self-Assessment Program (PSAP). The book focuses on the most up-to-date, evidence-based management strategies for

common infectious diseases encountered by pharmacists in any practice setting.

Infectious Diseases includes eight chapters divided into four learning modules. Chapter topics and the number of continuing pharmacy education (CPE) hours offered by each module are as follows: . Module I (5.5 CPE hours)

Urinary Tract InfectionsHepatitis C Virus Infection

Book Highlights . Module II (4.5 CPE hours)

Lower Respiratory Tract Infections Rhinosinusitis . Module III (4.5 CPE hours)Ophthalmic InfectionsEar Infections . Module IV (4.5 CPE hours)Lung AbscessesClostridium difficile Infection

Pharmacists interested in completing the modules toward CPE credit must successfully complete the associated tests by January 14, 2021. Board Certified Pharmacotherapy Specialists (BCPSs) interested in completing the modules toward specialty recertification credit must successfully com-plete the associated tests by May 15, 2018.

A sample chapter titled “Urinary Tract Infections” is avail-able at www.accp.com/docs/bookstore/psap/p2018b1_sam-ple.pdf. More information on Infectious Diseases is available at www.accp.com/store/product.aspx?pc=PSAP18_1.

2018 ACCP Global Conference on Clinical PharmacyOctober 20–23, 2018Seattle, Washington

Mark Your Calender

• •

•

•

•

•

•

•

American College of Clinical Pharmacy

ACCP International Clinical Pharmacist Winter 2018

3

Table. Global Conference on Clinical Pharmacy Abstract Submission

Decision Date Abstract Submission Deadline Abstract Categories

Early decision: accept/decline notification by April 16, 2018

February 15, 2018 Original Research; Systematic Reviews; Case Reports; Clinical Pharmacy Forum; Advances in International Clinical Pharmacy Practice, Edu-cation, or Training; and Research-in-Progress (includes abstracts by students, residents, and fellows)

Regular decision: accept/decline notification by August 15, 2018

June 15, 2018 Original Research; Systematic Reviews; Case Reports; Clinical Pharmacy Forum; and Advances in International Clinical Pharmacy Practice, Education, or Training

July 15, 2018 Research-in-Progress (includes abstracts by students, residents, and fellows)

2018 Global Conference on Clinical Pharmacy to Be Held in Seattle

The 2018 ACCP Global Conference on Clinical Pharmacy will be held October 20–23, 2018, in Seattle, Washington. Pharmacists and pharmacy leaders from across the globe will come together to learn about updates in therapeutic topics and current management strategies for various diseases and conditions of interest to the practicing pharmacist; advances in clinical pharmacy education, training, and research; and innovations in health care delivery and direct patient care ser-vices provided by pharmacists.

Pharmacists and pharmacy trainees interested in pre-senting their work are invited to submit their abstracts. The table below lists the deadlines for submitting to the various abstract categories for those interested in early (by April 16) and regular (by August 15) decision notification.

Detailed descriptions of each abstract category, includ-ing general instructions, structure, evaluation criteria, and abstract submission, are available at www.accp.com/abstracts/2018abstracts.

American College of Clinical Pharmacy

ACCP International Clinical Pharmacist Winter 2018

4American College of Clinical Pharmacy • 13000 W. 87th St. Parkway, Suite 100 • Lenexa, KS 66215 • (913) 492-3311 • (913) 492-0088 Fax • www.accp.com

ACCP International Clinical Pharmacist Winter 2018

4

A Message from the Editor

Dear Colleagues:

Articles in this issue of ACCP International Clinical Pharmacist highlight topics of importance to the advance-ment of clinical pharmacist credentials and clinical phar-macy practice.

The article titled “Cardiology and Infectious Diseases Pharmacy Specialty Certifications” reports on two new specialty certification examinations to be offered for the first time in fall 2018. Although pharmacists’ expertise in these specialty areas has been recognized by the Added Qualifications credential under the pharmacotherapy spe-cialty, beginning in 2018, pharmacists will hold the BCCP or BCIDP credential to recognize their competence in provid-ing advanced, specialized care in these areas.

The article titled “ACCP Launches a New Journal: JACCP” reports on the launch of a new journal that focuses on the practice of clinical pharmacy. Articles to be published in the journal will discuss advances in clinical pharmacy practice, including, but not limited to, education and training, care delivery models, credentialing and privileging, and patient outcomes. The journal will be the go-to resource for all prac-titioners, health care administrators, professional organiza-tions, health care policy-makers, and other stakeholders concerned with advancing pharmacy practice worldwide.

The Book Highlights department features the lat-est release from the Pharmacotherapy Self-Assessment Program (PSAP): Infectious Diseases. Topics covered in this book are relevant to pharmacists providing care to patients with various infectious diseases in any practice setting.

Finally, as the deadline for abstract submission approaches, pharmacists are urged to share findings from their practice and clinical research to be presented at the upcoming 2018 ACCP Global Conference on Clinical Pharmacy to be held October 20–23. Practicing pharma-cists, researchers, students and trainees, health care admin-istrators, and health care organization leaders from across the globe will converge in Seattle to learn about all matters related to clinical pharmacy practice. Abstract submission deadlines are outlined in the article titled “2018 Global Conference on Clinical Pharmacy to Be Held in Seattle.”

Sincerely,

Wafa Y. Dahdal, Pharm.D.

Enhancing the growth and evoluti on of clinical pharmacy

disc

iplin

e w

oldw

ide